BNTX - BioNTech SE Stock Price and Quote

BNTX [NASD]

Index	-	P/E	3.05	EPS (ttm)	43.28	Insider Own	64.01%	Shs Outstand	240.23M	Perf Week	2.81%
Market Cap	32.63B	Forward P/E	8.98	EPS next Y	14.71	Insider Trans	0.00%	Shs Float	215.11M	Perf Month	-3.30%
Income	10.95B	PEG	-	EPS next Q	8.84	Inst Own	17.00%	Short Float / Ratio	0.91% / 2.84	Perf Quarter	-23.51%
Sales	19.69B	P/S	1.66	EPS this Y	-8.00%	Inst Trans	11.87%	Short Interest	1.96M	Perf Half Y	0.62%
Book/sh	81.08	P/B	1.63	EPS next Y	-60.40%	ROA	51.60%	Target Price	212.61	Perf Year	-22.13%
Cash/sh	57.65	P/C	2.29	EPS next 5Y	-	ROE	65.50%	52W Range	117.08 - 188.99	Perf YTD	-10.76%
Dividend	-	P/FCF	2.50	EPS past 5Y	-	ROI	86.30%	52W High	-29.07%	Beta	0.24
Dividend %	-	Quick Ratio	5.30	Sales past 5Y	-	Gross Margin	81.70%	52W Low	14.49%	ATR	3.50
Employees	3082	Current Ratio	5.40	Sales Q/Q	-43.10%	Oper. Margin	75.70%	RSI (14)	50.82	Volatility	2.34% 2.64%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-43.50%	Profit Margin	55.60%	Rel Volume	0.64	Prev Close	132.08
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Mar 27 BMO	Payout	0.00%	Avg Volume	691.30K	Price	134.05
Recom	2.20	SMA20	2.53%	SMA50	-3.30%	SMA200	-9.70%	Volume	68,499	Change	1.49%

Dec-15-22

Upgrade

BofA Securities

Neutral → Buy

$239

Aug-17-22

Initiated

Cowen

Market Perform

$177

Jul-13-22

Upgrade

SVB Leerink

Mkt Perform → Outperform

Jul-06-22

Resumed

Canaccord Genuity

Buy

$192

Feb-01-22

Upgrade

Redburn

Sell → Neutral

Dec-16-21

Initiated

Morgan Stanley

Equal-Weight

$294

Nov-10-21

Upgrade

H.C. Wainwright

Neutral → Buy

$360

Oct-22-21

Initiated

Deutsche Bank

Hold

$250

Oct-07-21

Initiated

Jefferies

Hold

$230

Aug-11-21

Upgrade

Bryan Garnier

Neutral → Buy

$451

Show Previous Ratings

Mar-21-23 03:02AM	Sarepta Therapeutics (SRPT) Soars 7.1%: Is Further Upside Left in the Stock? Zacks
Mar-20-23 06:00PM	BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know Zacks
08:35AM	BioNTech inks deal with OncoC4 to develop cancer treatments MarketWatch
07:45AM	BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications GlobeNewswire
Mar-19-23 12:44PM	15 Most Promising Stocks to Buy According to Analysts Insider Monkey
10:00AM	Loading…
10:00AM	We Ran A Stock Scan For Earnings Growth And BioNTech (NASDAQ:BNTX) Passed With Ease Simply Wall St.
Mar-18-23 03:12AM	Matinas BioPharma Holdings, Inc. (AMEX:MTNB) Q4 2022 Earnings Call Transcript Insider Monkey
Mar-16-23 11:16PM	7 Stocks Set to Soar When the Market Recovers InvestorPlace
05:42AM	Q4 2022 Matinas BioPharma Holdings Inc Earnings Call Thomson Reuters StreetEvents
Mar-15-23 02:38PM	Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants Zacks
10:21AM	FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids Benzinga
08:39AM	FDA updates authorization of BioNTech, Pfizers bivalent booster for young children MarketWatch
Mar-14-23 07:01PM	U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids Reuters
04:26AM	Deciphera Pharmaceuticals, Inc. (DCPH) Soars 10.3%: Is Further Upside Left in the Stock? Zacks
Mar-13-23 06:00PM	BioNTech SE Sponsored ADR (BNTX) Gains As Market Dips: What You Should Know Zacks
07:45AM	Loading…
07:45AM	BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023 GlobeNewswire
07:00AM	Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St.
Mar-10-23 10:29AM	BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? Zacks
08:00AM	Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential Motley Fool
Mar-09-23 06:00AM	Investors in BioNTech (NASDAQ:BNTX) have made a enviable return of 356% over the past three years Simply Wall St.
Mar-06-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know Zacks
Mar-04-23 08:19AM	13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds Insider Monkey
Mar-03-23 09:07AM	12 Most Profitable Biotech Stocks Today Insider Monkey
Mar-01-23 10:31AM	Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5 Reuters
08:00AM	BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel GlobeNewswire
07:11AM	EU silence over Pfizer COVID contract talks is problem that won't go away -watchdog Reuters
Feb-27-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-24-23 05:06PM	The Next Generation Of Cancer Vaccines Is Coming; What That Means For Moderna And Other Biotech Stocks Investor's Business Daily
12:03PM	Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination Benzinga
09:43AM	UPDATE 2-Pfizer/BioNTech apply for full FDA approval of updated COVID vaccine Reuters
03:51PM	Loading…
Feb-22-23 03:51PM	12 Most Profitable Pharmaceutical Stocks Now Insider Monkey
Feb-21-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Stock Moves -0.79%: What You Should Know Zacks
Feb-19-23 07:59AM	BioNTech sees UK trials on cancer vaccines starting this year - paper Reuters
Feb-18-23 08:00AM	BioNTech SE (NASDAQ:BNTX) stock most popular amongst private equity firms who own 44%, while individual investors hold 20% Simply Wall St.
Feb-17-23 10:17AM	Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents Benzinga
Feb-16-23 11:05AM	Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents Reuters
Feb-14-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Gains As Market Dips: What You Should Know Zacks
04:33PM	11 Most Undervalued Biotech Stocks To Buy According To Hedge Funds Insider Monkey
06:00AM	Calculating The Intrinsic Value Of BioNTech SE (NASDAQ:BNTX) Simply Wall St.
Feb-10-23 07:00AM	Here's Why We Think BioNTech (NASDAQ:BNTX) Is Well Worth Watching Simply Wall St.
Feb-08-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Stock Moves -0.68%: What You Should Know Zacks
Feb-06-23 06:15AM	The 3 Most Undervalued Growth Stocks for Your February Buy List InvestorPlace
06:00AM	Investing in BioNTech (NASDAQ:BNTX) three years ago would have delivered you a 347% gain Simply Wall St.
Feb-04-23 08:00AM	Better Buy: Novavax or BioNTech Stock? Motley Fool
Feb-03-23 11:34AM	UPDATE 1-China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots Reuters
10:52AM	China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots Reuters
08:32AM	Implied Volatility Surging for BioNTech (BNTX) Stock Options Zacks
Feb-02-23 05:50PM	BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know Zacks
02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 InvestorPlace
09:25AM	UPDATE 1-BioNTech to invest $43 mln in German facility for mRNA vaccine building block Reuters
08:38AM	Germany's Scholz stresses need to speed up approvals process for pharma Reuters
06:45AM	BioNTech to invest $43 mln in German facility for mRNA vaccine building block Reuters
06:45AM	BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility GlobeNewswire
05:02AM	Analysts Just Slashed Their BioNTech SE (NASDAQ:BNTX) EPS Numbers Simply Wall St.
Jan-30-23 05:00AM	The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax Zacks
Jan-27-23 04:41PM	Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised) Zacks
04:08PM	Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip Investor's Business Daily
09:13AM	FDA Panel Endorses Simplification of COVID-19 Vaccine Strategy Zacks
Jan-26-23 07:31AM	Novavax (NVAX) COVID Jab Aids Growth, Overdependence A Woe Zacks
Jan-25-23 10:37AM	12 Cheap Biotech Stocks To Buy Insider Monkey
Jan-23-23 08:09AM	Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? Simply Wall St.
Jan-20-23 09:06AM	Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots Benzinga
Jan-19-23 10:17AM	Novavax (NVAX) Gets Nod for COVID-19 Booster Jab in South Korea Zacks
08:03AM	Israel says has not found a link between Pfizer COVID shot and stroke Reuters
Jan-18-23 01:14PM	EU drug regulator has not seen signal of possible Pfizer COVID shot stroke link Reuters
Jan-17-23 01:56PM	CDC to investigate safety signal for Pfizers updated COVID booster MarketWatch
10:34AM	WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating MarketWatch
Jan-13-23 06:15PM	REFILE-UPDATE 1-U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID shot link to stroke Reuters
04:22PM	U.S. says Pfizer's bivalent COVID shot may be linked to stroke in older adults Reuters
Jan-12-23 11:28AM	'We agree that vaccines should be free': Moderna's Noubar Afeyan Yahoo Finance
Jan-11-23 12:16PM	BioNTech seeks to have CureVac patent nullified in German court Reuters
Jan-10-23 11:55AM	BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup Benzinga
09:33AM	UPDATE 3-Germany's BioNTech buys British AI startup InstaDeep Reuters
09:22AM	BioNTech buys UK AI start-up InstaDeep in £562mn deal Financial Times
07:53AM	BioNTech to acquire AI company MarketWatch
07:15AM	BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development GlobeNewswire
04:59AM	Chinese bank tries to entice wealthy customers with mRNA vaccines Financial Times
Jan-09-23 01:40PM	Moderna Considers Price of $110-$130 for Covid-19 Vaccine The Wall Street Journal
12:50PM	Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly Benzinga
05:13AM	China still hasnt approved any mRNA vaccinesbut a new homegrown Omicron booster could break through Beijings barriers Fortune
Jan-08-23 08:00AM	Individual investors own 21% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control 44% of the company Simply Wall St.
Jan-06-23 03:43AM	BioNTech signs deal with UK for personalised cancer therapies Reuters
Jan-05-23 07:01PM	UK signs deal with BioNTech for cutting-edge cancer trials Financial Times
07:01PM	BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030 GlobeNewswire
04:15AM	RPT-UPDATE 1-German expats in China receive first foreign COVID vaccines Reuters
Jan-04-23 09:51AM	Bank of America Sees at Least 60% Gains in These 2 Stocks Heres Why They Could Soar TipRanks
09:00AM	A Look At The Intrinsic Value Of BioNTech SE (NASDAQ:BNTX) Simply Wall St.
Jan-02-23 07:00AM	Moderna/BioNTech: cancer vaccines will show mRNA not a one-trick pony Financial Times
Dec-30-22 06:50PM	Why BioNTech Was a Sickly Stock This Week Motley Fool
Dec-29-22 09:40AM	Are Investors Undervaluing BioNTech (BNTX) Right Now? Zacks
03:01AM	BioNTech is set to ship its first modular mRNA vaccine factory to Rwanda Quartz
Dec-28-22 09:13AM	3 Big Drug, Biotech Stocks to Boost Your Portfolio in 2023 Zacks -5.10%
06:45AM	BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference GlobeNewswire
06:20AM	Run on Vaccine Bookings, Medicines in Hong Kong as China Eases Travel Rules TheStreet.com
Dec-27-22 06:50PM	Analyst Report: BioNTech SE Morningstar Research -9.15%
Dec-23-22 05:24AM	UPDATE 1-BioNTech starts human trial to test malaria vaccine Reuters
04:42AM	BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate Reuters
03:00AM	BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165 GlobeNewswire
02:33AM	BioNTech's COVID booster vaccine approved in Hong Kong for individuals from age 12 Reuters
Dec-22-22 11:10PM	UPDATE 1-BioNTech vaccines for German expatriates in China have arrived at German embassy Reuters

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase 1a/1b clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 to treat solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II clinical trial to treat solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase II clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; Regeneron Pharmaceuticals, Inc. and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience